XORTX Therapeutics Inc. filed a Form 6-K with the SEC on February 24, 2025, indicating they will file annual reports under Form 20-F. This is a routine filing and does not indicate a significant event.
AI Assistant
XORTX THERAPEUTICS INC
2025
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.